Hosted on MSN

Samsung Biologics to acquire US drug manufacturing facility from GSK

Samsung Biologics will acquire a drug manufacturing facility in the United States from GlaxoSmithKline (GSK) for $280 million, marking its first production foothold in the country as it seeks to ...
Commercial Observer

Samsung Biologics to Acquire First U.S. Drug Manufacturing Facility in $280M Deal

A South Korean biomanufacturing giant is set to purchase its first drug production facility in the U.S. for a sum worthy of its tech giant parent. Samsung Biologics is the world’s largest contract ...
Seeking Alpha

Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK

INCHEON, South Korea, ROCKVILLE, Md. and LONDON , Dec. 21, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing ...
KSL

Health Secretary Kennedy speeds autism drug with UK-based GSK's help

WASHINGTON — Health Secretary Robert F. Kennedy Jr. could deliver a policy win for the Trump administration in just a few months after the Food and Drug Administration enlisted GSK to help it fast ...